{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:50:50Z","timestamp":1783486250434,"version":"3.55.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/17512433.2021.1931123","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T13:56:31Z","timestamp":1621346191000},"page":"955-961","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice"],"prefix":"10.1080","volume":"14","author":[{"given":"Shawn","family":"Gulati","sequence":"first","affiliation":[{"name":"University of Illinois at Chicago","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad A.","family":"Aref","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(54)92027-9"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(55)91845-6"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1984.tb12359.x"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00231357"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1980.tb06593.x"},{"key":"e_1_3_4_8_1","unstructured":"Wisfrand PJ Schenholm M Lonnerholm G Carbonic Anhydrase Isoenzymes CA I and CA II in the Human Eye.: 10."},{"issue":"8","key":"e_1_3_4_9_1","first-page":"802","article-title":"Evidence of a high-activity C type of carbonic anhydrase in human ciliary processes","volume":"18","author":"Wistrand PJ","year":"1979","unstructured":"Wistrand PJ, Garg LC. Evidence of a high-activity C type of carbonic anhydrase in human ciliary processes. Invest Ophthalmol Vis Sci. 1979;18(8):802\u2013806.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00506571"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1981.tb06918.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1976.03910030211008"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(57)90011-9"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1968.tb05917.x"},{"key":"e_1_3_4_15_1","first-page":"332","article-title":"PHOSPHATE AND PROTEIN CONCENTRATIONS OF INTRAOCULAR FLUIDS. I. EFFECT OF CARBONIC ANHYDRASE INHIBITION IN YOUNG AND OLD RABBITS","volume":"2","author":"Constant MA","year":"1963","unstructured":"Constant MA, Falch J. PHOSPHATE AND PROTEIN CONCENTRATIONS OF INTRAOCULAR FLUIDS. I. EFFECT OF CARBONIC ANHYDRASE INHIBITION IN YOUNG AND OLD RABBITS. Invest Ophthalmol. 1963;2:332\u2013343.","journal-title":"Invest Ophthalmol"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(56)91268-5"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(60)91000-X"},{"key":"e_1_3_4_18_1","first-page":"52","article-title":"The measurement of rate of aqueous flow with iodide","volume":"1","author":"Becker B","year":"1962","unstructured":"Becker B. The measurement of rate of aqueous flow with iodide. Invest Ophthalmol. 1962;1:52\u201358.","journal-title":"Invest Ophthalmol"},{"issue":"5","key":"e_1_3_4_19_1","first-page":"927","article-title":"Aqueous humor turnover rates in the cat. I. Effect of acetazolamide","volume":"4","author":"Macri FJ","year":"1965","unstructured":"Macri FJ, Dixon RL, Rall DP. Aqueous humor turnover rates in the cat. I. Effect of acetazolamide. Invest Ophthalmol. 1965;4(5):927\u2013934.","journal-title":"Invest Ophthalmol"},{"issue":"1","key":"e_1_3_4_20_1","first-page":"76","article-title":"Measurement of aqueous humor formation rates by posterior-anterior chamber perfusion with inulin: normal values and the effect of carbonic anhydrase inhibition","volume":"6","author":"Oppelt WW","year":"1967","unstructured":"Oppelt WW. Measurement of aqueous humor formation rates by posterior-anterior chamber perfusion with inulin: normal values and the effect of carbonic anhydrase inhibition. Invest Ophthalmol. 1967;6(1):76\u201383.","journal-title":"Invest Ophthalmol"},{"key":"e_1_3_4_21_1","unstructured":"Stamper RL Lieberman MF Drake MV Carbonic anhydrase inhibitors.: 13."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(85)90004-2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1957.tb01139.x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(55)90022-2"},{"issue":"2","key":"e_1_3_4_25_1","first-page":"209","article-title":"Ocular and systemic effects of acetazolamide in nephrectomized rabbits","volume":"23","author":"Friedman Z","year":"1982","unstructured":"Friedman Z, Krupin T, Becker B. Ocular and systemic effects of acetazolamide in nephrectomized rabbits. Invest Ophthalmol Vis Sci. 1982;23(2):209\u2013213.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"e_1_3_4_26_1","first-page":"730","article-title":"The pharmacology of methazolamide in relation to the treatment of glaucoma","volume":"16","author":"Maren TH","year":"1977","unstructured":"Maren TH, Haywood JR, Chapman SK, et al. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol Vis Sci. 1977;16(8):730\u2013742.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(77)90134-9"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1986.01050180076033"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070020209026"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1980.01020031041005"},{"key":"e_1_3_4_31_1","unstructured":"Acetazolamide: Drug information - UpToDate. Accessed 2021 Jan 8. https:\/\/www.uptodate.com\/contents\/acetazolamide-drug-information?search=acetazolamide&source=panel_search_result&selectedTitle=1~110&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.12.027"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)75247-X"},{"issue":"2","key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"e00016","DOI":"10.1097\/j.jcro.0000000000000016","article-title":"Bilateral transient myopia induced by oral acetazolamide in the early postoperative period after phacoemulsification","volume":"8","author":"Kalina PH","year":"2020","unstructured":"Kalina PH, Kalina AG. Bilateral transient myopia induced by oral acetazolamide in the early postoperative period after phacoemulsification. JCRS Online Case Rep. 2020;8(2):e00016.","journal-title":"JCRS Online Case Rep"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2016.04.002"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1580\/08-WEME-LE-259R1.1"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1960.00950020317015"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1956.00930030550013"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.72980200006009c"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1957.tb02240.x"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1952.tb00014.x"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32808738d5"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20170080"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2010.12.032"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S38324"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(62)93283-X"},{"key":"e_1_3_4_47_1","unstructured":"Diamox Sequels (acetazolamide) [prescribing information]. July 2008. Accessed 2021 Jan 9. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/205358Orig1s000lbl.pdf"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31828f2701"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3182594001"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02399.x"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000641"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)87238-0"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12048"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.9.856.36106"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp120291"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E350"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.5.e584"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2002.33774"},{"issue":"25","key":"e_1_3_4_59_1","first-page":"1228","article-title":"[Fatal anaphylactic reaction after oral acetazolamide (diamox) for glaucoma]","volume":"144","author":"Gerhards LJ","year":"2000","unstructured":"Gerhards LJ, Van Arnhem AC, Holman ND, et al. [Fatal anaphylactic reaction after oral acetazolamide (diamox) for glaucoma]. Ned Tijdschr Geneeskd. 2000;144(25):1228\u20131230.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2013.11.008"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00921.x"},{"issue":"6","key":"e_1_3_4_62_1","first-page":"829","article-title":"Ocular emergencies","volume":"76","author":"Pokhrel PK","year":"2007","unstructured":"Pokhrel PK, Loftus SA. Ocular emergencies. Am Fam Physician. 2007;76(6):829\u2013836.","journal-title":"Am Fam Physician"},{"key":"e_1_3_4_63_1","first-page":"CD010746","article-title":"Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty","volume":"2","author":"Zhang L","year":"2017","unstructured":"Zhang L, Weizer JS, Musch DC. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst Rev. 2017;2:CD010746.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70235-4"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1995.tb04392.x"},{"key":"e_1_3_4_66_1","first-page":"44","article-title":"The pharmacokinetics of acetazolamide during CAPD","volume":"10","author":"Schwenk MH","year":"1994","unstructured":"Schwenk MH, Blaustein DA, Wagner JD. The pharmacokinetics of acetazolamide during CAPD. Adv Perit Dial Conf Perit Dial. 1994;10:44\u201346.","journal-title":"Adv Perit Dial Conf Perit Dial"},{"issue":"1","key":"e_1_3_4_67_1","first-page":"89","article-title":"Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteers","volume":"16","author":"Yue CS","year":"2013","unstructured":"Yue CS, Huynh HH, Raymond C, et al. Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteers. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2013;16(1):89\u201398.","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2021.1931123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:27:53Z","timestamp":1770942473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2021.1931123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/17512433.2021.1931123"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2021.1931123","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}